Jingfeng Zhang Selected Research

Jingfeng Zhang Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 09/2008
5	Infections 01/2022 - 02/2015
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2016
2	Arthritis (Polyarthritis) 01/2021 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2017
1	familial dilated cardiomyopathy 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Heart Failure 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Newcastle Disease 01/2022
1	Inflammation (Inflammations) 09/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2021
1	Rare Diseases (Rare Disease) 05/2021
1	Carcinoma (Carcinomatosis) 05/2021
1	Meningioma (Meningiomas) 05/2021
1	Overweight 01/2021
1	Obesity 01/2021
1	Subcutaneous panniculitis-like T-cell lymphoma 01/2021
1	Polyps 12/2020
1	Cattle Diseases (Bovine Diseases) 12/2020
1	COVID-19 11/2020
1	Synovitis 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Hemangiosarcoma (Angiosarcoma) 06/2018
1	Sarcoma (Soft Tissue Sarcoma) 03/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2016
1	Esophageal Squamous Cell Carcinoma 07/2015
1	Liver Neoplasms (Liver Cancer) 02/2009

Drug/Important Bio-Agent (IBA)

4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2015
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 09/2008
2	Pharmaceutical PreparationsIBA 01/2017 - 10/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Mitogen-Activated Protein Kinase 10IBA 01/2022
1	phospholambanIBA 01/2022
1	EndotoxinsIBA 09/2021
1	IsoflavonesIBA 06/2021
1	Glucose (Dextrose)FDA LinkGeneric 05/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Ampicillin (Omnipen)FDA LinkGeneric 12/2020
1	AntitoxinsIBA 12/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2020
1	polyphosphate kinaseIBA 12/2020
1	EnzymesIBA 12/2020
1	Guanosine PentaphosphateIBA 12/2020
1	Guanosine TetraphosphateIBA 12/2020
1	ChemokinesIBA 11/2020
1	Chemokine CCL5IBA 11/2020
1	Nucleic AcidsIBA 11/2020
1	Pattern Recognition ReceptorsIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	CytokinesIBA 11/2020
1	Interleukin-8 (Interleukin 8)IBA 11/2020
1	Y-Box-Binding Protein 1IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Keratin-18 (Keratin 18)IBA 01/2019
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 06/2018
1	Antisense RNA (Anti-Sense RNA)IBA 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Competitive Endogenous RNAIBA 01/2016
1	Biological ProductsIBA 07/2015
1	CokeIBA 03/2014
1	rho GTPase-activating proteinIBA 02/2009
1	Therapeutic UsesIBA 09/2008

Therapy/Procedure

3	Therapeutics 03/2018 - 09/2008
1	Drug Therapy (Chemotherapy) 01/2021
1	Intra-Arterial Infusions 01/2020
1	Microspheres (Microsphere) 01/2020